Pentwater Capital Management LP Bioventus Inc. Transaction History

Pentwater Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$12.37 - $16.77 $412,762 - $559,581	-33,368 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.7 - $17.25 $8,658 - $10,902	-632 Reduced 1.86%	33,368 $472,000
Q2 2021 Aug 16, 2021	SELL	$13.75 - $18.8 $288,750 - $394,800	-21,000 Reduced 38.18%	34,000 $598,000
Q1 2021 May 17, 2021	BUY	$11.49 - $19.21 $631,950 - $1.06 Million	55,000 New	55,000 $840,000

142

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $619M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.